| Treatment of Recalcitrant Neovascular AMD Using Brolocizumab With Immediate T&E (NCT05710471) | The University of Hong Kong | 2022-07-25 |
| Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD (NCT05438732) | VisionCare, Inc. | 2022-06-16 |
| Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants (NCT04697095) | Hospices Civils de Lyon | 2022-06-01 |
| An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration (NCT05300724) | Genentech, Inc. | 2022-05-27 |
| Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals (NCT05763940) | Western University of Health Sciences | 2022-05-25 |
| Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT) (NCT05447650) | i-Lumen Scientific, Inc. | 2022-04-12 |
| Device for Age-related Macular Degeneration (AMD) (NCT06178978) | University of Michigan | 2022-03-10 |
| Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells (NCT05187104) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2022-03-01 |
| A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration (NCT05230537) | Novartis Pharmaceuticals | 2022-02-17 |
| Visual Remapping to Aid Reading With Field Loss (NCT03848663) | University of Minnesota | 2022-02-01 |
| Impact of Regular Consumption of Grapes on Eye Health in Singapore Older Adults (NCT05064865) | National University of Singapore | 2022-01-28 |
| Early Feasibility Study Using IOPCL MAG to Improve Near Vision in ARMD Subjects (NCT04984590) | OnPoint Vision Inc | 2022-01-21 |
| Subthreshold Laser Treatment in Intermediate Age-related Macular Degeneration With Nascent Geographic Atrophy Study (NCT05200624) | Center for Eye Research Australia | 2021-12-13 |
| A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders (NCT05112861) | Outlook Therapeutics, Inc. | 2021-11-15 |
| Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD (NCT05003245) | Shanghai Henlius Biotech | 2021-11-01 |
| A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing Orientation and Mobility Training (NCT05135195) | NYU Langone Health | 2021-10-24 |
| A Study of Implantation of Retinal Pigment Epithelium in Subjects with Acute Wet Age Related Macular Degeneration (NCT01691261) | Moorfields Eye Hospital NHS Foundation Trust | 2021-10-14 |
| A Study to Evaluate the Safety and Efficacy of RQC for AMD (NCT05062486) | Paul A Knepper, MD PhD | 2021-10-04 |
| Effectiveness of Prism Spectacles in Patients With Age Related Macular Degeneration (NCT05437302) | University of Faisalabad | 2021-10-04 |
| Observational Study of Vision Improvement in Patients With Retinal Disorders (NCT04693702) | Optimal Acuity Corporation | 2021-10-01 |
| MP-3 Biofeedback Training and Central Vision Loss (NCT05772780) | Amore Filippo | 2021-10-01 |
| Adaptive Optics Imaging of Outer Retinal Diseases (NCT05355415) | Food and Drug Administration (FDA) | 2021-08-27 |
| Adherence to Lifestyle Changes for Age-related Macular Degeneration (NCT05667441) | Erasmus Medical Center | 2021-08-01 |
| Possible Effects of Supplement Therapy With Oral Phenolics on Cluster of Differentiation 163 (CD-163) Biomarker of Patients With Age-related Macular Degeneration (NCT05005884) | Shahid Beheshti University of Medical Sciences | 2021-07-28 |
| Evaluate the Safety and Efficacy of HLX04-O in Subjects With wAMD (NCT04993352) | Shanghai Henlius Biotech | 2021-07-15 |
| Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration (NCT04679935) | Novartis Pharmaceuticals | 2021-07-13 |
| A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD (NCT04740671) | Shanghai Henlius Biotech | 2021-07-01 |
| RBM-007 in Treatment naïve Exudative Age-related Macular Degeneration (NCT04895293) | Maturi, Raj K., M.D., P.C. | 2021-06-15 |
| Metabolomics: A Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration (NCT04241536) | Association for Innovation and Biomedical Research on Light and Image | 2021-06-01 |
| QA102 Phase 1 Study in Healthy Young and Older Adult Subjects (NCT04894071) | Smilebiotek Zhuhai Limited | 2021-05-17 |
| AI for the Detection of Retinal Disease and Glaucoma in Patients With Diabetes Mellitus in Primary Care (NCT04132401) | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 2021-05-01 |
| Analysis of naïve Patients With Age-related Macular Degeneration of the Neovascular Type and Treated With Aflibercept (Eylea®) in "Treat-and-extend" at CHU Brugmann (NCT04891835) | Laurence Postelmans | 2021-04-13 |
| Assessing the Quality of Life and Social Support in Age-Related Macular Degeneration Patients (NCT05427994) | Asfendiyarov Kazakh National Medical University | 2021-04-05 |
| Visual Outcome After Vitrectomy With Subretinal tPA Injection (NCT05196139) | Universitaire Ziekenhuizen KU Leuven | 2021-04-01 |
| Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study (NCT05963646) | Institute of Molecular and Clinical Ophthalmology Basel | 2021-03-16 |
| The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections (NCT05615805) | University of Oklahoma | 2021-03-01 |
| Effect of Micronutrient Supplementation on the Intestinal Microbiota in Patients With Age-related Macular Degeneration - The Gut-Retina-axis Study (NCT06391411) | Azienda Ospedaliero-Universitaria Careggi | 2021-03-01 |
| Visual Function Change in Wet Age-related Macular Degeneration Patients With Better Baseline Visual Acuity (NCT06330220) | Seoul National University Hospital | 2021-02-10 |
| Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD (NCT04735263) | Massachusetts Eye and Ear Infirmary | 2021-02-04 |
| Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression (NCT04739319) | Center for Eye Research Australia | 2021-02-02 |
| Macula Evolution in Patients With AMD Taking Oral Food Supplementation (NCT04778436) | Laboratoires Thea | 2021-01-13 |
| Beovu Experience UZ Leuven (NCT05220085) | Universitaire Ziekenhuizen KU Leuven | 2020-12-01 |
| Oral Postbiotics in Patients With Macular Atrophy (NCT05391074) | Institut de la Macula y la Retina | 2020-12-01 |
| Ocular Coherence Tomography During Cataract Assessment (NCT05287269) | Brighton and Sussex University Hospitals NHS Trust | 2020-11-02 |
| Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients (NCT04590196) | University of Illinois at Chicago | 2020-11-01 |
| A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD） (NCT04572698) | Luye Pharma Group Ltd. | 2020-11-01 |
| A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders (NCT04516278) | Outlook Therapeutics, Inc. | 2020-10-01 |
| Association of MPOD Values With Blue Light. (NCT04779398) | The University of Queensland | 2020-09-25 |
| Eye Movement Rehabilitation in Low Vision Patients (NCT04929756) | Northeastern University | 2020-09-04 |
| Study of Photobiomodulation Effect on Electroretinogram Outcomes in Dry Age-Related Macular Degeneration (NCT04522999) | LumiThera, Inc. | 2020-08-20 |
| Online Validation of Dietary Intake Food Frequency Questionnaire Over Four Weeks, and Electronic Device Use Questionnaire Over Eight Weeks. (NCT04779411) | The University of Queensland | 2020-08-18 |
| A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects (NCT04486963) | Tasly Pharmaceutical Group Co., Ltd | 2020-07-24 |
| Telemedicine in Age-Related Macular Degeneration (NCT04863391) | The New York Eye & Ear Infirmary | 2020-07-19 |
| Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents (NCT04395859) | Fondation Ophtalmologique Adolphe de Rothschild | 2020-05-27 |
| Mitochondrial DNA in Vitreous Fluid and Blood in Patients With Eye Disease or Ocular Trauma. (NCT04334499) | The University of Texas Medical Branch, Galveston | 2020-02-21 |
| Study of the Discriminating Power of a Blood Biomarker for Omega-3 Polyunsaturated Fatty Acid Content of the Retina for Age-related Macular Degeneration (AMD) (NCT04278300) | Centre Hospitalier Universitaire Dijon | 2020-02-11 |
| Analysis of the Intestinal Microbiome in Patients With Wet Age-related Macular Degeneration (NCT05757674) | University of Ioannina | 2020-01-10 |
| Study Evaluating Retinal Health Monitoring System Visual Acuity Module. (NCT04169802) | Kubota Vision Inc. | 2019-11-20 |
| Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - PINNACLE (NCT04269304) | University of Southampton | 2019-10-28 |
| Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections (NCT04142164) | Prim. Prof. Dr. Oliver Findl, MBA | 2019-10-24 |
| Functionally Validated Structural Endpoints for Early AMD (NCT04112667) | Cynthia Owsley | 2019-10-07 |
| Efficacy and Safety of Aflibercept in Patients With Neovascular Age-related Macular Degeneration (NCT05587062) | Cinnagen | 2019-10-01 |
| Biomarkers of Common Eye Diseases (NCT04101604) | Sun Yat-sen University | 2019-09-26 |
| Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON) (NCT04005352) | Novartis Pharmaceuticals | 2019-09-25 |
| A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular Degeneration (NCT02873351) | Snyder, Robert W., M.D., Ph.D., P.C. | 2019-09-01 |
| OCTA and Retinal Angiomatous Proliferation (NCT04689789) | Federico II University | 2019-09-01 |
| Eyes That Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proportion of the Real-World Patient Population and Reasons for Exclusion (NCT04836143) | Kim's Eye Hospital | 2019-08-26 |
| Age-related Macular Degeneration (AMD) and Cardiovascular Disease (NCT04087356) | The New York Eye & Ear Infirmary | 2019-08-02 |
| Optimising Visual Acuity Measurement in Macular Degeneration (NCT04920071) | Moorfields Eye Hospital NHS Foundation Trust | 2019-07-25 |
| Povidone Iodine vs AVEnova: A Pre-injection Disinfection Study (PAVE Study) (NCT04018482) | California Retina Consultants | 2019-07-16 |
| Evaluation of the Performance of Self-monitoring Optimized by Therapeutic Education in the Recurrence of Wet Age-related Macular Degeneration (AMD) (NCT04032808) | Clinique Beau Soleil | 2019-07-10 |
| A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) (NCT03834753) | Outlook Therapeutics, Inc. | 2019-06-25 |
| Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD (NCT03954626) | Novartis Pharmaceuticals | 2019-06-07 |
| Implantation of SML in Patients With Dry Age-related Macular Degeneration and Myopic Maculopathy (NCT03882606) | Consorci Sanitari de Terrassa | 2019-05-22 |
| Global Atrophie Biomarker Evaluation Study (GABiE) (NCT03935126) | Boehringer Ingelheim | 2019-05-07 |
| Imaging of the Angiofibrotic Switch in Neovascular AMD (NCT03838679) | Medical University of Vienna | 2019-05-01 |
| Village-Integrated Eye Worker Trial II (NCT03752840) | University of California, San Francisco | 2019-04-21 |
| Association Between Age-related Macular Degeneration and Cognitive Impairment Based on Exosome Proteomics (NCT06883461) | Shanghai 10th People's Hospital | 2019-04-01 |
| ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA (NCT03891875) | Stealth BioTherapeutics Inc. | 2019-03-27 |
| A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration (NCT03869684) | Senju Pharmaceutical Co., Ltd. | 2019-02-25 |
| Assessment of Visual Function With a Portable Brain-computer Interface (NCT03760055) | NGoggle | 2019-02-11 |
| Effect of Corona Virus on Intravitreal Injections (NCT05494775) | Benha University | 2019-02-01 |
| Removal of Massive Subretinal Organized Blood Clot With Fragmatome (NCT04196049) | Changhua Christian Hospital | 2019-01-07 |
| Surgical Outcome of Macular Membrane Peeling Associated With Significant Macular Drusen (NCT03927430) | Klinikum Chemnitz gGmbH | 2019-01-01 |
| Stem Cells Therapy in Degenerative Diseases of the Retina (NCT03772938) | Pomeranian Medical University Szczecin | 2018-12-13 |
| Evaluation of the Safety and Efficacy of ALS-L1023 Administered in Combination With Ranibizumab in Patients With Wet-AMD (NCT03725501) | AngioLab, Inc. | 2018-12-07 |
| Assay of Pro-angiogenic Cytokines in Exudative Age-Related Macular Degeneration (NCT03630562) | Centre Hospitalier Universitaire de Nice | 2018-11-26 |
| Safety and Tolerability of Oral CM082 in Patients With wAMD (NCT03710863) | AnewPharma | 2018-11-22 |
| A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration (NCT04151212) | Bio-Thera Solutions | 2018-10-30 |
| Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections (NCT03710564) | Novartis Pharmaceuticals | 2018-10-30 |
| A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) (NCT03844074) | Outlook Therapeutics, Inc. | 2018-10-01 |
| Age-Related Macular Degeneration, Scotopic Dysfunction, and Driving Performance in a Simulator (NCT03166202) | University of Alabama at Birmingham | 2018-09-01 |
| Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial (NCT03609307) | Shahid Beheshti University of Medical Sciences | 2018-09-01 |
| RBM-007 in Subjects witH ExudatIve Age-related Macular Degeneration (NCT03633084) | Ribomic USA Inc | 2018-08-29 |
| A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration (NCT03178149) | Astellas Institute for Regenerative Medicine | 2018-07-13 |
| Carbidopa-Levodopa in Dry AMD With Geographic Atrophy (NCT03451500) | Snyder, Robert W., M.D., Ph.D., P.C. | 2018-07-01 |
| FLIO and the Influence of Oral Lutein Supplementation on Macular Pigment (NCT04761341) | Insel Gruppe AG, University Hospital Bern | 2018-06-01 |
| Automatic Self Transcending Meditation (ASTM) for Patients With Severe Age Related Macular Degeneration (AMD) (NCT03104608) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2018-06-01 |
| Village-Integrated Eye Worker Trial II - Pilot (NCT03278587) | University of California, San Francisco | 2018-05-31 |
| Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation (NCT03478878) | National Eye Institute (NEI) | 2018-05-14 |